Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258K Buy
+2,518
New +$257K ﹤0.01% 1485
2025
Q3
$396K Buy
+4,581
New +$362K ﹤0.01% 963

Other funds holding NUVL

CIBC Bancorp USA's NUVL Position: Q1 2026 in Review

CIBC Bancorp USA opened a new position in Nuvalent (NUVL) in Q1 2026: 2,518 shares worth $258K. The stake represents ﹤0.01% of the portfolio and ranks #1485 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in NUVL as recently as Q3 2025.

CIBC Bancorp USA first reported a position in NUVL in Q3 2025 and has held it in 2 quarters since. The position peaked at $396K in Q3 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • CIBC Bancorp USA held 2,518 shares of Nuvalent worth $258K as of Q1 2026.
  • Nuvalent was a new CIBC Bancorp USA position in Q1 2026.
  • Nuvalent made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q1 2026, its #1485 holding.
  • CIBC Bancorp USA first reported a position in Nuvalent in Q3 2025 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Nuvalent position peaked at $396K in Q3 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on CIBC Bancorp USA's 13F filing for Q1 2026, filed 12 May 2026.